France
11
2012-07-05
11
2016-01-12
These are the the leading inventors for applications assigned to Flamel Technologies:
Flamel Technologies based in , FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
N-phosphonomethylglycine guanidine derivative salts
#2 | 2012-06-12 ✅ Patent 8,197,850 granted on 2012-06-12Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same
#3 | 2012-01-24 ✅ Patent 8,101,209 granted on 2012-01-24Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
#4 | 2010-04-15 ✅ Patent 8,445,023 granted on 2013-05-21Anti-misuse microparticulate oral pharmaceutical form
#5 | 2010-02-11 ✅ Patent 8,293,255 granted on 2012-10-23Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof, in particular for therapeutic purposes
#6 | 2009-12-10 ✅ Patent 8,206,744 granted on 2012-06-26Branched polyamino acids functionalized with hydrophobic groups, and applications thereof particularly therapeutic applications
#7 | 2009-04-30 ✅ Patent 8,017,156 granted on 2011-09-13Long-acting colloidal insulin formulation and its preparation
#8 | 2009-01-08 ✅ Patent 8,481,019 granted on 2013-07-09Modified-release particles of polyelectrolytes and pharmaceutical formulations thereof
#9 | 2009-01-08 ✅ Patent 8,236,353 granted on 2012-08-07Self-precipitating pharmaceutical formulations for the modified release of an active principle
#10 | 2007-08-23 ✅ Patent 8,084,045 granted on 2011-12-27Pharmaceutical formulations for the prolonged release of active principle(s) and their applications
#11 | 2005-12-01 ✅ Patent 8,507,003 granted on 2013-08-13Compressed tablets comprising microcapsules with modified release
443568 ⎘